A Small-Molecule Activation Mechanism That Directly Opens the KCNQ2 Channel
Shaoying Zhang,Demin Ma,Kun Wang,Ya Li,Zhenni Yang,Xiaoxiao Li,Junnan Li,Jiangnan He,Lianghe Mei,Yangliang Ye,Zongsheng Chen,Juwen Shen,Panpan Hou,Jiangtao Guo,Qiansen Zhang,Huaiyu Yang
DOI: https://doi.org/10.1038/s41589-023-01515-y
IF: 14.8
2024-01-01
Nature Chemical Biology
Abstract:Pharmacological activation of voltage-gated ion channels by ligands serves as the basis for therapy and mainly involves a classic gating mechanism that augments the native voltage-dependent open probability. Through structure-based virtual screening, we identified a new scaffold compound, Ebio1, serving as a potent and subtype-selective activator for the voltage-gated potassium channel KCNQ2 and featuring a new activation mechanism. Single-channel patch-clamp, cryogenic-electron microscopy and molecular dynamic simulations, along with chemical derivatives, reveal that Ebio1 engages the KCNQ2 activation by generating an extended channel gate with a larger conductance at the saturating voltage (+50 mV). This mechanism is different from the previously observed activation mechanism of ligands on voltage-gated ion channels. Ebio1 caused S6 helices from residues S303 and F305 to perform a twist-to-open movement, which was sufficient to open the KCNQ2 gate. Overall, our findings provide mechanistic insights into the activation of KCNQ2 channel by Ebio1 and lend support for KCNQ-related drug development. Identification of a small molecule (Ebio1) reveals a unique activation mechanism for the KCNQ2 potassium channel. Ebio1 induces a twist-to-open movement in the S6 helices, creating an extended channel gate with enhanced conductance.